Leonteq Securities AG Sells 23,619 Shares of Corteva, Inc. $CTVA

Leonteq Securities AG decreased its holdings in Corteva, Inc. (NYSE:CTVA) by 67.4% in the 1st quarter, Holdings Channel.com reports. The firm owned 11,443 shares of the company’s stock after selling 23,619 shares during the period. Leonteq Securities AG’s holdings in Corteva were worth $958,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. JPL Wealth Management LLC purchased a new stake in shares of Corteva during the 3rd quarter valued at approximately $25,000. Garton & Associates Financial Advisors LLC purchased a new position in Corteva in the 4th quarter valued at approximately $27,000. Bank of Jackson Hole Trust bought a new stake in Corteva during the 4th quarter valued at $28,000. Cornerstone Financial Management LLC purchased a new stake in shares of Corteva during the fourth quarter worth $29,000. Finally, Basepoint Wealth LLC purchased a new stake in shares of Corteva during the fourth quarter worth $30,000. Institutional investors own 81.54% of the company’s stock.

Corteva Stock Down 0.2%

CTVA opened at $85.63 on Friday. The firm has a market capitalization of $57.27 billion, a P/E ratio of 50.37, a price-to-earnings-growth ratio of 2.62 and a beta of 0.56. Corteva, Inc. has a one year low of $60.53 and a one year high of $85.95. The company has a fifty day moving average price of $79.80 and a 200-day moving average price of $76.86. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The company had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm’s revenue was up 11.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were issued a $0.18 dividend. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.8%. Corteva’s dividend payout ratio (DPR) is presently 42.35%.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Jefferies Financial Group lifted their price target on Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Morgan Stanley increased their price objective on Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, May 28th. Barclays raised their target price on Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a research note on Thursday, June 11th. BNP Paribas Exane upped their price target on Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Finally, Royal Bank Of Canada increased their price target on shares of Corteva from $95.00 to $97.00 and gave the stock an “outperform” rating in a report on Thursday, May 7th. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $88.90.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.